Showing results (421-430 of 633) with videos related to

Sort By:
Pageof 64
Pathology, Research and Practice|March 23, 2001
Expression of tyrosine kinase receptors Tie-1 and Tie-2 in giant cell tumor of the tendon sheath: a possible role in synovial proliferationM Nakashima, T Uchida, T Tsukazaki, et al.
International Journal of Oncology|May 11, 2011
Establishment of a new human uterine cervical adenocarcinoma cell-line, siso, and its reactivity to anticancer reagentsK Sonoda, M Nakashima, T Saito, et al.
Clinical Orthopaedics and Related Research|September 1, 1990
Characterization of cells cultured from human giant-cell tumors of bone. Phenotypic relationship to the monocyte-macrophage and osteoclastS Komiya, Y Sasaguri, A Inoue, et al.
Life Sciences|May 18, 1999
Prevention of ischemia-induced hippocampal neuronal damage by 2-deoxy-D-glucose in gerbilsM Niwa, A Hara, T Iwai, et al.
European Journal of Pharmacology|December 29, 1998
Role of histamine H1 and H2 receptor antagonists in the prevention of intimal thickeningN Miyazawa, S Watanabe, A Matsuda, et al.
Journal of Pharmacological and Toxicological Methods|June 1, 1993
A simple and reproducible cerebral thrombosis model in rats induced by a photochemical reaction and the effect of a plasminogen-plasminogen activator chimera in this modelH Matsuno, T Uematsu, K Umemura, et al.
European Journal of Pharmacology|February 16, 1993
Roles of platelet-activating factor, thromboxane A2, ADP and thrombin in thrombogenesis in the guinea pigY Hirata, Y Takiguchi, K Wada, et al.
Methods and Findings in Experimental and Clinical Pharmacology|September 24, 2005
Pharmacodynamic study of procaterol hydrochloride dry powder inhaler: evaluation of pharmacodynamic equivalence between procaterol hydrochloride dry powder inhaler and procaterol hydrochloride metered-dose inhaler in asthma patients in a randomized, double-dummy, double-blind crossover mannerM Kawai, A Sakai, S Takaori, et al.
Biological & Pharmaceutical Bulletin|January 1, 1997
Electrophysiologic effects of nitrous oxide, a volatile anesthetic, in dogs following myocardial infarction in comparison with other anestheticsH Hashimoto, S Imamura, S Watanabe, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Design of a suitable formulation of FK613, a novel antiallergic agent, based on its pharmacokinetic and pharmacodynamic properties in healthy subjectsT Uematsu, S Nagashima, H Inaba, et al.
Pageof 64